Molecular testing can add useful evidence to cancer care. EmbryoGenomics works with clinicians to align the test with the clinical question and the sample available.
Selected inherited variants may be assessed when personal or family history raises a question about inherited risk.
Tumour molecular profiling
Testing may examine selected molecular features in tumour material, subject to specimen suitability and panel scope.
Treatment planning support
Results can contribute to a wider clinical discussion. A qualified oncology team interprets findings alongside other evidence.
Molecular insight for clinical conversations
We help clinicians and care teams clarify the testing question, understand sample requirements and coordinate a report suited to the agreed pathway. Genomic findings are one part of care planning and should be interpreted by the treating team.
Discuss your oncology testing needs
Our team can help clarify test scope, sample requirements and the next step for a clinician-led request.